Shanghai Composite (SSEC.NDX)

Close: 3 444.58 (+2.45), Dec 4, 2020
Weak Negative

Automatic technical analysis. Medium term, Dec 4, 2020

Shanghai Composite is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index is moving within a rectangle formation between support at 3236 and resistance at 3452. A decisive break through one of these levels indicates the new direction for the index. The index is testing the resistance at points 3450. This could give a negative reaction, but an upward breakthrough of points 3450 means a positive signal. Volume tops and volume bottoms correspond badly with tops and bottoms in the price. This weakens the rising trend and could be an early signal for a coming trend break. The index is overall assessed as technically slightly negative for the medium long term.

Recommendation one to six months: Weak Negative

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.84%4 152.83+0.07%
5 days-80.222.93%3 027.75+1.06%
22 days-18.007.27%2 174.85+5.10%
66 days-24.4513.13%2 096.15+3.45%

More analyses of Shanghai Composite

chart Shanghai Composite (SSEC) Candlesticks 22 Days
Candlesticks
chart Shanghai Composite (SSEC) Short term
Short term: Positive
chart Shanghai Composite (SSEC) Medium term
Medium term: Weak Negative
chart Shanghai Composite (SSEC) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now